Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
Physiology & Behavior2014Vol. 129, pp. 194–198
Citations Over TimeTop 14% of 2014 papers
Elson Asevedo, Lucas B. Rizzo, Ary Gadelha, Rodrigo B. Mansur, Vanessa Ota, Arthur de Almeida Berberian, Bruno Sini Scarpato, Antônio Lúcio Teixeira, Rodrigo A. Bressan, Elisa Brietzke
Related Papers
- → Plasma total antioxidant status and cognitive impairments in schizophrenia(2012)70 cited
- → Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome(2014)32 cited
- → Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits(2021)16 cited
- → Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: A case-control study(2013)25 cited
- Cognitive impairment of schizophrenia patients with diabetes(2010)